Therapeutic compounds

Details Therapeutic compounds Therapeutic compounds

2007-11-06

2007-11-06

Richter, Johann R. (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C544S295000

Reexamination Certificate

active

11129277

ABSTRACT:
The invention provides compounds of formula (I),prodrugs and stereoisomers thereof, and the pharmaceutically acceptable salts of the compounds, prodrugs, and stereoisomers, wherein R1, R2, R3, HET, n, Q, X, Y, and Z are as described herein; compositions thereof; and uses thereof in treating diabetic complications including diabetic neuropathy, diabetic nephropathy, diabetic microangiopathy, and the like.

REFERENCES:
patent: 2003/0078317 (2003-04-01), Lin et al.
patent: 2003/0121450 (2003-07-01), Lin et al.
patent: 2003/0167093 (2003-09-01), Xu et al.
patent: 2003/0216777 (2003-11-01), Tien et al.
patent: 2004/0003757 (2004-01-01), Chern Lin et al.
patent: 2004/0022825 (2004-02-01), Lagow
patent: 2004/0031420 (2004-02-01), Lin et al.
patent: 2004/0076685 (2004-04-01), Tas
patent: 2004/0137032 (2004-07-01), Wang
patent: 2004/0175320 (2004-09-01), Lin et al.
patent: 2004/0180091 (2004-09-01), Lin
patent: 2004/0185181 (2004-09-01), Matsumoto
patent: 2004/0186481 (2004-09-01), Chern Lin et al.
patent: 2005/0069479 (2005-03-01), Lin et al.
patent: 2005/0076813 (2005-04-01), Lin et al.
patent: 2005/0101964 (2005-05-01), Lin et al.
patent: 2428271 (2002-05-01), None
patent: 1308439 (2003-05-01), None
patent: 1426366 (2004-06-01), None
patent: 1535906 (2005-06-01), None
patent: 06-228011 (1994-08-01), None
patent: 04026820 (2004-01-01), None
patent: 2005-170792 (2005-06-01), None
patent: 05139107 (2005-06-01), None
patent: WO9534538 (1995-12-01), None
patent: WO 02076450 (2002-10-01), None
patent: WO 03000250 (2003-01-01), None
patent: WO 03002531 (2003-01-01), None
patent: WO 03002553 (2003-01-01), None
patent: WO 03035057 (2003-05-01), None
patent: WO 03/055418 (2003-07-01), None
patent: WO 03057144 (2003-07-01), None
patent: WO 03057666 (2003-07-01), None
patent: WO 03095425 (2003-11-01), None
patent: WO 03101449 (2003-12-01), None
patent: WO 03101958 (2003-12-01), None
patent: WO 2004007446 (2004-01-01), None
patent: WO 2004043940 (2004-05-01), None
patent: WO 2004046106 (2004-06-01), None
patent: WO 2004050022 (2004-06-01), None
patent: WO 2004071454 (2004-08-01), None
patent: WO 2004092128 (2004-10-01), None
patent: WO 2004110436 (2004-12-01), None
patent: WO 2004112701 (2004-12-01), None
patent: WO 2005009956 (2005-02-01), None
patent: WO 2005023762 (2005-03-01), None
patent: WO 2005042533 (2005-05-01), None
patent: WO 2005044195 (2005-05-01), None
Vippagunta et al Advanced Drug Delivery Reviews, vol. 48, pp. 3-26 (2001).
Caldwell, C.G., et al., “Fluoropyrrolidine amides as dipeptidyl peptidase IV inhibitors”,Bioorganic&Medicinal Chemistry Letters, vol. 14, pp. 1265-1268 (2004).
Lu, I., et al., “Glutamic acid analogues as potent dipeptidyl peptidase IV and 8 inhibitors”,Bioorganic&Medicinal Chemistry Letters, vol. 15, pp. 3271-3275 (2005).
Mastracchio, A., et al., “Heterocycle Fused Cyclohexylglycine Derivatives as Novel Dipeptidyl Peptidase-IV Inhibitors”,Heterocycles, vol. 82, pp. 203-206 (2004).
Augustyns, KJL., et al., “Pyrrolidides: synthesis and structure-activity relationship as inhibitors of dipeptidyl peptidase IV”,Eur J Med Chem.,vol. 32, pp. 301-309 (1997).
Sakashita, H., et al., “1-((S)-γ-Substituted prolyl)-(S)-2-cyanopyrrolidine as novel series of highly potent DPP-IV inhibitors”,Bioorganic&Medicinal Chemistry Letters, vol. 15, pp. 2441-2445 (2005).
Xu, J., et al., “Discovery of potent and selective phenylalanine based dipeptidyl peptidase IV inhibitors”,Bioorganic&Medicinal Chemistry Letters, vol. 15, pp. 2533-2536 (2005).
Fukushima, H., “Synthesis and structure-activity relationships of potent 3- or 4-substituted-2-cyanopyrrolodine dipeptidyl peptidase IV inhibitors”,Bioorganic&Medicinal Chemistry, vol. 12, pp. 6053-6061 (2004).

Affiliated with

Also associated with

Rating

Therapeutic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3849391